Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-30 @ 4:44 PM
Study NCT ID:
NCT03217903
Status:
UNKNOWN
Last Update Posted:
2019-08-06
First Post:
2017-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)
Sponsor:
Central Hospital, Nancy, France
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-03
First Submit QC Date:
None
Study First Post Date:
2017-07-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-05
Last Update Post Date:
2019-08-06
Last Update Post Date Type:
ACTUAL